M. Kolpen 1 , M. Kühl 2 , T. Bjarnsholt 1 , C.R. Hansen 3 , T. Pressler 3 , L.L.H. Møller 2 , N. Høiby 1 , P.Ø. Jensen 1 . 1 Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark; 2 University of Copenhagen, Marine Biological Section, Department of Biology, Copenhagen, Denmark; 3 Copenhagen CF Center, Rigshospitalet, Copenhagen, Denmark Objective: Chronic lung infection with Pseudomonas aeruginosa is the major severe complication in cystic fibrosis (CF) patients, where P. aeruginosa proliferates in biofilms in the endobronchial mucus under hypoxic conditions. Numerous polymorphonuclear leukocytes (PMNs) surround the biofilm and are major consumers of O 2 . We hypothesized that P. aeruginosa can acquire energy for growth in anaerobic endobronchial mucus by denitrification, which can e.g. be demonstrated by production or degradation of nitrous oxide (N 2 O), an intermediate in the denitrification pathway. Methods: We measured concentration profiles of O 2 and N 2 O with microsensors in fresh expectorated sputum from CF patients with chronic P. aeruginosa infection. The concentration of PMNs was estimated by flow cytometry. The Griess reagent assay was used to measure the concentration of NO − 3 and NO − 2 in sputum samples. Results: In purulent sputum from 9 CF patients, N 2 O production occurred only in layers where O 2 was absent or at low concentrations (median 30.8 mM N 2 O; range 1.4-157.9 mM N 2 O). During the initial period of measurements the concentration of N 2 O increased followed by a period of decreasing N 2 O concentration. In addition, the concentration of PMNs correlated to the concentration of NO − 3 (P < 0.04, r 2 : 0.66, n = 10) and NO − 2 (P < 0.006, r 2 : 0.78, n = 11). Conclusion: The present study demonstrates for the first time production of N 2 O in human sputum. Our results thus show that P. aeruginosa can acquire energy for growth via denitrification in hypoxic endobronchial mucus of CF patients. As a source of endobronchial NO − 3 and NO − 2 we suggest the summoned PMNs. Objectives: To complement research using CF animal models, we have developed and characterized a multi-cellular model of human airways, using co-cultures of fibroblasts with bronchial epithelial cells at air-liquid interface (ALI). The aim of this work was to determine if our model of CF airways displays the hyperinflammatory responses characteristic of the disease. Methods: Cells were grown at ALI for at 14 days to allow differentiation, as measured by transepithelial electrical resistance. Mono-and co-cultures were challenged with LPS (extracted from P. aeruginosa and B. cenocepacia), heat inactivated bacteria or live bacteria. Challenges were applied either to the apical side of polarised cultures, into the basal compartment or to both sides at once. Supernatants were harvested after 24 hours and ELISA analysis performed for IL-8. Conclusion: Epithelial monocultures did not respond to challenge with LPS or heat inactivated bacteria; in fact IL-8 secretion was only increased following application of live bacteria to the apical compartment. Under these conditions, for non-CF epithelial cultures, apical release of IL-8 was~400pg/ml, approximately double basolateral levels, suggesting directed release of IL-8. At baseline, CF epithelial cell monocultures secreted equivalent levels of IL-8 to non-CF, but importantly, the response to live bacteria was exaggerated in CF cultures (~900 pg/ml IL-8).
The non-CF co-culture model also only responds to live bacteria applied apically.
We are now investigating the response of CF co-culture models to confirm the presence of the hyper-inflammatory phenotype. We would like to thank the Humane Research Trust for funding.
